Shareholding disclosure

T. Rowe Price Associates, Inc

Declared position

5.14%

Threshold

Crossed upwards

Timeline

Published

24.09.2022

Transaction

16.09.2022

Voting rights breakdown

Voting rights acquired5.14%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAM9N00028

Beneficial owner

T. Rowe Price Associates, Inc

Declared address

T. Rowe Price Associates, Inc., Baltimore, MD 21202

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

T. Rowe Price Associates, Inc

PolyPeptide Group AG24.09.2022TAM9N00028

Disclosure summary

T. Rowe Price Associates, Inc disclosed a holding in PolyPeptide Group AG on the acquisition side, published by SIX Exchange Regulation on 24.09.2022, at 5.14% of voting rights. Notice category: Single shareholder.

Disclosed position

5.14%

Voting rights acquired

Voting rights acquired5.14%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

T. Rowe Price Associates, Inc disclosed a holding in PolyPeptide Group AG, published on 24.09.2022.

Publication date24.09.2022

Transaction date16.09.2022

Issuing companyPolyPeptide Group AG

Beneficial ownerT. Rowe Price Associates, Inc

Declared addressT. Rowe Price Associates, Inc., Baltimore, MD 21202

CategorySingle shareholder

Voting rights acquired5.14%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAM9N00028

Source: SIX Exchange Regulation · Publication date: 24.09.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open